Citation: G. Singh et Dr. Ramey, NSAID-INDUCED GASTROINTESTINAL COMPLICATIONS - THE ARAMIS PERSPECTIVE-1997, Journal of rheumatology, 25, 1998, pp. 8-16
Authors:
SINGH G
RAMEY DR
TRIADAFILOPOULUS G
BROWN BW
BALISE RR
Citation: G. Singh et al., GI SCORE - A SIMPLE SELF-ASSESSMENT INSTRUMENT TO QUANTIFY THE RISK OF SERIOUS NSAID-RELATED GI COMPLICATIONS IN RA AND OA, Arthritis and rheumatism, 41(9), 1998, pp. 256-256
Authors:
SINGH G
RAMEY DR
BALISE R
TRIDAFLIOPOULOS G
Citation: G. Singh et al., EPIDEMIOLOGY OF NSAID-RELATED GI COMPLICATIONS IN PATIENTS WITH OSTEOARTHRITIS (OA) - A 13 YEAR PROSPECTIVE-STUDY, Arthritis and rheumatism, 41(9), 1998, pp. 885-885
Citation: Jf. Fries et Dr. Ramey, ARTHRITIS SPECIFIC GLOBAL HEALTH ANALOG SCALES ASSESS GENERIC HEALTH-RELATED QUALITY-OF-LIFE IN PATIENTS WITH RHEUMATOID-ARTHRITIS, Journal of rheumatology, 24(9), 1997, pp. 1697-1702
Citation: Jf. Fries et al., RESPONSE TO THERAPY IN RHEUMATOID-ARTHRITIS IS INFLUENCED BY IMMEDIATELY PRIOR THERAPY, Journal of rheumatology, 24(5), 1997, pp. 838-844
Authors:
SINGH G
TERRY R
RAMEY DR
TRIADAFILOPOULUS G
BROWN BW
Citation: G. Singh et al., GI SCORE - A SIMPLE SELF-ASSESSMENT INSTRUMENT TO QUANTIFY THE RISK OF SERIOUS NSAID-RELATED GI COMPLICATIONS, Arthritis and rheumatism, 40(9), 1997, pp. 377-377
Authors:
SINGH G
TERRY R
RAMEY DR
TRIADAFILOPOULOS G
BROWN BW
Citation: G. Singh et al., EPIDEMIOLOGY OF SERIOUS NSAID-RELATED COMPLICATIONS - A PROSPECTIVE MULTIVARIATE LIFETABLE ANALYSIS, Arthritis and rheumatism, 40(9), 1997, pp. 1094-1094
Authors:
SINGH G
RAMEY DR
MORFELD D
SHI H
HATOUM HT
FRIES JF
Citation: G. Singh et al., GASTROINTESTINAL-TRACT COMPLICATIONS OF NONSTEROIDAL ANTIINFLAMMATORYDRUG-TREATMENT IN RHEUMATOID-ARTHRITIS - A PROSPECTIVE OBSERVATIONAL COHORT STUDY, Archives of internal medicine, 156(14), 1996, pp. 1530-1536
Citation: Jf. Fries et al., MEDICAL COSTS ARE STRONGLY ASSOCIATED WITH DISABILITY LEVELS IN RHEUMATOID-ARTHRITIS (RA), Arthritis and rheumatism, 38(9), 1995, pp. 208-208
Citation: Jf. Fries et al., RESPONSE TO THERAPY IN RHEUMATOID-ARTHRITIS (RA) IS DEPENDENT UPON IMMEDIATELY PRIOR THERAPY, Arthritis and rheumatism, 38(9), 1995, pp. 1296-1296
Citation: Jf. Fries et al., SUGGESTED GUIDELINES FOR MONITORING LIVER TOXICITY IN RHEUMATOID-ARTHRITIS PATIENTS TREATED WITH METHOTREXATE - COMMENT, Arthritis and rheumatism, 37(12), 1994, pp. 1829-1830
Citation: Jf. Fries et al., THE RELATIVE TOXICITY OF ALTERNATIVE THERAPIES FOR RHEUMATOID-ARTHRITIS - IMPLICATIONS FOR THE THERAPEUTIC PROGRESSION, Seminars in arthritis and rheumatism, 23(2), 1993, pp. 68-73
Citation: G. Singh et al., THE COSTS OF IMMUNOSUPPRESSIVE THERAPY FOR RHEUMATOID-ARTHRITIS, Arthritis and rheumatism, 36(9), 1993, pp. 190000178-190000178
Citation: G. Singh et al., A TOXICITY INDEX FOR COMPARISON OF THE GASTROINTESTINAL TOXICITY OF NONSTEROIDAL ANTIINFLAMMATORY DRUGS (NSAIDS), Arthritis and rheumatism, 36(9), 1993, pp. 190000178-190000178
Citation: Dr. Ramey et al., RISK-FACTORS FOR NSAID-ASSOCIATED GASTROPATHY IN RHEUMATOID-ARTHRITISAND OSTEOARTHRITIS, Arthritis and rheumatism, 36(9), 1993, pp. 190000194-190000194